CLINICAL_TRIALS
trial_result
· 2012-10-16
Clinical Trial Update: Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy [Phase 1]
Summary
A Phase 1 trial of an anti-VEGFR vaccine therapy for neovascular age-related macular degeneration (neovascular maculopathy) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Osaka University | Conditions: Neovascular Maculopathy, Age Related Macular Degeneration | Phase 1 | Status: COMPLETED